SUMMARY A genetic analysis has been made of published and new data on the familial occurrence of severe pre-eclampsia in primigravid women. This has shown that the condition may be largely a Mendelian recessive one. Because the condition occurs only in pregnancy, and because susceptible women cannot otherwise be identified, it is difficult to decide whether the genotype of the parent or of the offspring carried in utero leads to the condition. Data on the incidence of severe pre-eclampsia in the relatives of women who have suffered eclampsia support the maternal genotype hypothesis, while similar data, in which the index cases were women who had had severe pre-eclampsia, are more compatible with the fetal genotype hypothesis. Data on the incidence of the condition in blood relatives of index cases compared to the incidence in their corresponding in-laws are now required. Such a comparison would allow a choice to be made between the two hypotheses if one or the other were correct, or would assess the contribution of each if a genotype x genotype interaction were involved. Recurrent severe pre-eclampsia seems to have the same genetic basis as the more common primigravid type. However, mild, that is non-proteinuric, pre-eclampsia usually seems to be inherited independently of the severe form.
Severe pre-eclampsia or pregnancy-induced severe hypertension is a common cause of perinatal death in Britain (Baird, 1977) . Eclampsia, the epilepticlike seizure which occasionally results from severe pre-eclampsia, is an important cause of maternal death from child-bearing (DHSS, 1974) . Despite much research effort throughout this century their primary cause remains unknown (Chesley, 1978) . Several immunogenetic hypotheses on the aetiology of severe pre-eclampsia have been put forward (Kalmus, 1946; Penrose, 1946; Platt et al., 1958) . Very recently, reports have appeared showing that there is an unusual distribution of HLA types both in women who have had the condition and in their husbands Redman et al., 1978) . This has led Redman and his colleagues to suggest that recessive maternal immune response genes linked to HLA may predispose towards severe preeclampsia. Although close female relatives of sufferers from the condition also have a high incidence, no attempt seems to have been made to see if its inheritance is Mendelian. On the basis of our own and published family data we show here that severe pre-eclampsia could be largely a simple recessive trait, but we cannot say whether it is the genotype Received for publication 26 February 1979 of the mother or her fetus which predisposes towards the condition.
Materials and methods
All the data analysed are on women who have been examined clinically for blood pressure and urinary protein, and with the exception of the eclamptic index cases in Chesley et al. (1962 in Chesley et al. ( , 1968 all women were primigravidae. The details of the definition of the condition and collection of data differ for the different bodies of data.
ABERDEEN DATA
In our own data and those of Adams and Finlayson (1961) , the classification of Nelson (1955) is used. Nelson defined pre-eclampsia as the condition in which a rise of diastolic blood pressure to 90 mmHg or higher occurs after the 26th week of pregnancy on two occasions at least one day apart, or else shows a progressive increase during labour. He further defined severe pre-eclampsia as proteinuria exceeding 025 g/l in addition to the hypertension; nonproteinuric pre-eclampsia is referred to as mild pre-eclampsia. Applying this definition, Macgillivray (1958) found 5 6% of women in the Aberdeen Maternity Hospital in Scotland in the years 1948 to 1955 had severe pre-eclampsia in their first pregnancy, but only 0 3 % had it in their second pregnancy. Thus, severe pre-eclampsia as defined by Nelson occurs mainly in first pregnancy. More than 90% of all Aberdeen primigravidae were confined in this hospital during this period, and so the figures are probably representative of the whole population. We have used Macgillivray's data on the incidence in first pregnancy as the frequency of homozygotes for the putative gene for severe pre-eclampsia, h (normal allele H). The data of Adams and Finlayson appear to have been collected for women who were pregnant mainly in the 1950s, and so their figures may be compared with Macgillivray's.
Our data are for primigravid women in the Aberdeen Maternity Hospital in the years 1968 to 1972, during which the incidence of severe preeclampsia was 5 3% (W. A. Liston, unpublished data) . During this period also, more than 90% of pregnant women in the area were confined there. All women who had had severe pre-eclampsia in this hospital in 1968 to 1972 were included in the survey, together with an approximately equal number of mild pre-eclamptic and normal women. Data on the incidence in their mothers were obtainable if the mothers had also been delivered in this hospital. No attempt was made to obtain data on those who delivered elsewhere. Sisters were identified by writing to the index cases and asking them for information on their sisters' married name. The index cases were told that the survey concerned pregnancy-induced hypertension. Information on the incidence in sisters was obtained only if the index cases responded to the questionnaire and their sisters were delivered in the hospital. The percentages of index cases for whom information concerning mother or sister was obtained are shown in Table 1 . Adams and Finlayson (1961) (Jenkins, 1976 Table 1 ) and so p of her daughters will be susceptible to severe pre-eclampsia. (b) Fetal genotype hypothesis. Under this hypothesis, the fetus is considered to be the index case, and to have the recessive genotype hh. That is, the hh genotype in the fetus leads to severe pre-eclampsia in the mother. The ratio of HH plus Hh to hh among the fetuses of daughters of the original pre-eclamptic mother will be 1-p :p and so p of these daughters will develop severe pre-eclampsia. As noted in the text, this rule applies only if the daughter is first born. p2 (2+p) p2(4+ 3p)
Here p is the pregnancy of the putative gene for severe pre-eclampsia, ie the population frequency of the condition itself is p2. The derivation of the expectations assume random mating. The proportion of normal subjects can be obtained by subtracting the proportion of affected subjects from one.
(1) Note that if there is more than one daughter per family, these ratios are only valid if a mother is counted each time one of her daughters is used as an index case. (2) In the data of Chesley et al. (1962 Chesley et al. ( , 1968 where many eclamptic index cases experienced their eclampsia in later pregnancies, these ratios would apply to the daughters born in the eclamptic pregnancy.
(3) For the Chesley data these apply to daughters not born in the eclamptic pregnancy.
Some discrimination between the two hypotheses is possible for sister-pair data. There will be a high correlation between phenotypes of sisters if the maternal genotype hypothesis is correct, but for the fetal genotype hypothesis the predicted correlation is much lower, because the fetus of the index case and the fetus of her sister are merely cousins.
In addition, data on the incidence of the condition in blood relatives of index cases compared to their in-laws also discriminate between the two hypotheses ( Fig. 2, Table 2 ). If the fetal genotype hypothesis is hh Fig. 2 Predictions of the fetal genotype hypothesis for severe pre-eclampsia; identity of expectations for blood relatives of affected index cases and their corresponding in-laws, using mother and mother-in-law as an example.
Hatching and arrow indicate affected index case. Squares are males, circles females, and diamonds may be of either sex. All women with an hh fetus in their first pregnancy will have severe pre-eclampsia. (Strictly speaking the hh offspring should be regarded as the index case under the fetal genotype hypothesis, but here we maintain the usual convention of regarding the affected mother as the index case.) The gene frequency is p, and h is the gene for the condition. Expectations for the different classes of relative are given in Table 2 . E is hh. Prob (C is hh) = prob (D is hh) = p. Hence prob (A has condition) = prob (B has condition) = p. Similar relationships hold for daughters and daughters-in-law, and sisters and sisters-in-law.
Mothers carry hh fetuses correct the incidence in mothers should equal that in mothers-in-law, the incidence in sisters should equal that in sisters-in-law, and the incidence in daughters should equal that in daughters-in-law. If the maternal genotype hypothesis is correct, the incidence in the in-laws should equal that in the general population. (The usefulness of a comparison between data on blood relatives and corresponding in-laws is not confined to severe pre-eclampsia; the approach could provide a general method for assessing the relative contribution of maternal and fetal genotypes in any characteristic of pregnancy, for example gestation length and maternal hormonal levels.)
Because severe pre-eclampsia manifests itself predominantly in first pregnancies, the birth order of daughters in a pedigree affects the expected ratios for the fetal genotype hypothesis, irrespective of whether the daughters are index cases or daughters of index cases (Table 2 ). This dependence on birth order means that the identity of expectations depicted in Fig. 1 for mother-daughter data for the two hypotheses holds only if the daughter is first born. If the daughter is born of a later pregnancy, the (Table 2) . Essentially, this difference between the expectations arises because not all daughters can be tested for their capacity to cause severe pre-eclampsia by being born in a first pregnancy, but all mothers must have a first pregnancy and so be tested for their susceptibility. The expectations for in-laws on the fetal hypothesis are also correspondingly different for first born sons as opposed to later born sons.
Dominant inheritance in either the maternal or the fetal generation seems unlikely; the nature of the evidence against it is illustrated in the footnote to Table 3 .
Results

INHERITANCE
In Tables 3, 4 , and 5 we present analyses of data published by Adams and Finlayson (1961) Table 6 . Sisters and sisters-in-law have Table 3 . ns, not significant; nd, not done because expectation was too low; *, significant at 5 % level; **, significant at 1 % level; ***, significant at 0-001 % level. Chesley (1978) it would seem that 6% is the probable frequency of toxaemia in primigravid North American whites. But in view of Chesley's expressed doubts about the consistency with which the diagnosis of toxaemia was made from hospital to hospital, it seems preferable not to use this figure, even though it is very similar to that obtained by Macgillivray (1958) for Aberdeen. Instead, the values of p have been estimated from the data itself by the maximum likelihood procedure of Fisher as outlined in Mather (1964) . The expectations are given in Table 2 . After estimation, the particular value of p is then substituted back into these formulae and agreement with the observed values tested by x2. Data are from Chesley et al. (1962 from Chesley et al. ( , 1968 . See text for relation between severe pre-eclampsia and toxaemia. Maternal genotype hypothesis, p = 0-256, X22 = 0.71, P = 0-70. Since these data were used in another form in Table 6 to help estimate p, a degree of freedom is lost and x22 = 0 09, P>0-90, a non-significant departure. See text for relationship between severe pre-eclampsia and toxaemia. *Expected proportion of families with at least one pre-eclamptic daughter = 1-(l-p)n where n = number of daughters and p = gene frequency= 0-256 (Table 6 ). **Expectation was calculated using n = 4. very different incidences (2 x 2 contingency X21 = 20-79, P<0-001). The incidence in sisters-in-law is low (8y%). The correlation between sisters is much higher than in the Scottish data; 54/147 (36 7%) sisters of eclamptic index cases had severe preeclampsia. Thus, the analysis unequivocally supports the maternal genotype hypothesis.
In Table 7 an analysis is made of Chesley's data on the incidence of families of eclamptic women in which there is at least one toxaemic daughter. They exhibit the pattern typical of maternal recessive inheritance. Assessment of their agreement with fetal recessive inheritance is not possible in the absence of information on whether the daughters were born of the toxaemic pregnancy or not. Table 8 shows the incidence of mild pre-eclampsia among relatives of normal, mild, and severe index cases. The incidence of the mild form is highest among the relatives of the mild index cases, although it is only in the Adams and Finlayson (1961) sister data that this reaches statistical significance. There is a very slight suggestion that less mild pre-eclampsia occurs among the relatives of normal as opposed to severe index cases, but in none of the three bodies of data is the difference between them significant. The 2 x 2 contingency table x2 values are: mothers 0x64, P = 0 5 to 0 3; sisters (this paper) 0 53, P = 0 5 to 0O3; sisters (Adams and Finlayson, 1961) 3 07, P = 0 10 to 0 05. We conclude that severe preeclampsia and mild pre-eclampsia are usually inherited independently of each other.
RELATION BETWEEN SEVERE PRE-ECLAMPSIA IN FIRST AND LATER PREGNANCIES
In agreement with Macgillivray (1958) our data show that severe pre-eclampsia is much less common in second pregnancies (Table 9 ). The incidence of the condition in the second pregnancies of those who have had it in the first pregnancy is 11 %. This is significantly higher than the incidence in the second pregnancies of those who had mild pre-eclampsia (2 x 2 contingency x2 with Yates's correction = 4X72, P = 0 05 to 0 02). This suggests that the severe pre-eclampsia of later pregnancies is the result of the same genetic predisposition which leads to the condition in first pregnancies. Chesley's data agree with this (Table 10 ). The incidence of toxaemia in daughters of the index cases who had their eclampsia in first pregnancy is almost identical to the incidence in daughters of those who had their eclampsia in a later pregnancy (2 x 2 contingency X21 = 0-03, P>0-90).
Discussion
All hospital data are subject to possible ascertainment bias. In the Aberdeen data only 30% ascertainment of mothers was obtained, and we do not D. W. Cooper and W. A. Liston Table 9 Incidence ofsevere pre-eclampsia in second viable pregnancy in women who had normal, mild, or severe pre-eclampsia in first pregnancy (percentages in brackets). Aberdeen data know if the remaining 70 % delivered at home or in hospital. If women with the condition tend to enter hospital relatively more frequently than women with normal pregnancies, our incidence figures could be biased upwards. However, since mothers of normal daughters and sisters of normal sisters had incidences very close to the population figure, as predicted by the expectations in Table 2 , it is unlikely that this particular bias has distorted the Aberdeen figures. Ascertainment in Chesley's data was 96% for daughters and 86% for sisters, and so a significant bias for these data is unlikely also Although figures are lacking, there is a widespread clinical impression that the incidence of severe preeclampsia in Western countries has declined in recent years Sisters. Adams and Finlayson (1961) 90/379 (24) 47/118 (39) 20/58 (34) 12-70** ns, not significant; ",significant at the 1 % level.
group.bmj.com on May 1, 2017 -Published by http://jmg.bmj.com/ Downloaded from and hypertension, and do not directly measure the clinical status of the women. Perhaps the practice of early induced delivery of potential sufferers has reduced the incidence of what is recognised by clinicians as severe pre-eclampsia, without affecting the incidence of proteinuria and hypertension.
The North American data support the maternal genotype hypothesis, but the Scottish data point towards the fetal genotype hypothesis. The resolution of this paradox may lie in the fact that two rather different groups of index cases were considered, primigravid and multigravid eclamptics for the North American series and Nelson's type of severe pre-eclamptic for the Scottish series. We suggest two possible explanations consistent with the available data.
(1) For most cases the fetal genotype hypothesis may be correct, but in order for eclampsia to result, other genes may have to be present in the maternal genome. These maternal genes may by themselves also predispose towards severe pre-eclampsia, hence the high correlation between sisters in the North American data (Tables 6 and 7) . Eclampsia is a rare condition, and so these genes would also presumably be a less common cause of severe pre-eclampsia in the general population. This genotype x genotype interaction is depicted diagrammatically in Fig. 3 415 may develop in their first pregnancy the condition defined by Nelson's criteria, that is penetrance may not be complete. This implies that mild pre-eclampsia (hypertension in pregnancy without significant proteinuria) may sometimes be a manifestation of the genes which cause severe pre-eclampsia. However, our analysis shows that most cases of mild preeclampsia seem to be inherited independently of the severe form. This is in agreement with other data which show that mild pre-eclampsia is distinct from severe pre-eclampsia in at least three ways. (i) Its incidence increases sharply after the age of 30 whereas that of severe preeclampsia is constant with age (Nelson, 1955) .
(ii) Women who have had mild pre-eclampsia have an increased incidence of hypertension in later life while severe pre-eclampsia is uncorrelated with later hypertension (Adams and Macgillivray, 1961; Chesley et al, 1962) . (iii) Mild pre-eclampsia occurs in the second pregnancies ofabout a third of the women who have either severe or mild pre-eclampsia in their first pregnancy, while severe preeclampsia is uncommon in later pregnancies (Macgillivray, 1958, and Table 9 ). Severe pre-eclampsia is said to be very common in women with hydatidiform moles, which are derived from trophoblast tissue . Such moles have recently been shown to be androgenetic in origin, that is, they possess two identical sets of paternal chromosomes and have no maternal contribution (Kajii and Ohama, 1977) . They are therefore haploid or largely haploid from a population genetics standpoint. On the fetal genotype hypothesis, the expected incidence of severe preeclampsia should be much higher than in the general population (p vs p2), and so these observations support this hypothesis rather than the maternal hypothesis.
The suggestion that the phenotype of the mother may be influenced by the genotype of the offspring she carries in utero has a precedent. Milk yield in cattle is influenced by the genotype of the sire of the calf whose birth initiated the lactation (Skjervold and Fimland, 1975) . In goats, placental lactogen levels in pregnancy are correlated with the degree of mammary gland development (Hayden et al, 1978) . It may be that in cattle the sire's genetic contribution could affect placental lactogen production which in turn could affect mammary gland development and milk yield.
There is some debate as to whether the severe preeclampsia which occurs in later pregnancies has the same cause as the more common primigravid condition (Chesley, 1978) . The data in Table 9 and the equivalent incidences in daughters of primigravid and multigravid eclamptic index cases (Table 10) suggest that most cases in parous women are the result of the same genetic predisposition which affects nulliparous women.
Recessive inheritance usually implies absent or defective gene product. A number of writers have discussed the idea that severe pre-eclampsia may be the result of an aberrant immune reaction initiated by first exposure to the foreign paternal antigens of the placenta (Jenkins, 1976; Scott and Beer, 1976; Redman et al., 1978; Scott et al., 1978) . How such an aberrant immune response could lead to severe pre-eclampsia is still conjectural. If either of the two simple genetic hypotheses are correct, it may be possible by immunological techniques to recognise the phenotype of women at risk before they become pregnant. Prior immunisation with the relevant paternal antigens could then prevent severe preeclampsia. Since they hold out this possibility of treatment, the simple genetic hypotheses should be thoroughly investigated.
